Nov 24, 2020

Childhood Dementia Initiative set up to to create awareness and uncover the shocking impacts of childhood dementia

On November 23rd, an event held at Parliament House revealed a troubling health system blind spot. Childhood Dementia Initiative launched their organisation at this event, along with the release of a Burden of Disease and White Paper report, to detail the extent, impact and horrific nature of childhood dementia.

These reports expose that a disease that is usually only associated with the elderly has fatal impacts on children across Australia and the world.

Childhood Dementia Initiative are circulating these reports to uncover the shocking impacts of childhood dementia, and also showcase the significant need to transform the way research and clinical care is currently delivered for childhood dementia disorders.

Dementia in childhood has long been recognised by the medical community, but the collective group of disorders that cause childhood dementia have received little attention from the public, governments and research funders.

Established by CEO Megan Donnell, CDI is the first organisation of its kind, with a vision to end childhood dementia through awareness, fundraising and significant research.

As previous CEO of the Sanfilippo Foundation and seven years of professional and lived experience in the space, Ms Donnell identified key gaps in the research and has since dedicated her career to driving the representation of childhood dementia on a global scale.

“With less than five percent of all identified conditions that lead to childhood dementia having a treatment, it is time to transform the way we approach childhood dementia. Children are dying, we need to act fast,” Ms Donell said.

There are currently an estimated 700,000 children and young people living with dementia worldwide, with many young lives being devastatingly shaped by progressive brain damage, social isolation, suffering and early mortality rates.

With the disease being largely underrepresented and unknown, the new organisation hopes to secure philanthropic funding in order to drive awareness of the disease and its breadth, expedite research and advocate for systemic change in how research has been traditionally undertaken.

The Burden of Disease report has revealed that each year 129 children in Australia are born with a condition that will lead to Childhood Dementia. In 2021, it is estimated that there will be 2,273 Australians living with the disease.

“This report highlights the size, scale and wide-reaching impacts of childhood dementia and, importantly, outlines the overwhelming opportunity to act. The Childhood Dementia Initiative is launching to do just that.” Ms Donnell said.

It is estimated that 1 in 2,800 children are born with a disorder that, if untreated, leads to childhood dementia. These findings reveal that it is more common than well-known disorders, including cystic fibrosis.

Despite the devastating nature of childhood dementia and its collective incidence, prevalence and mortality rate being largely comparable with well-known diseases such as cystic fibrosis, motor neurone disease and childhood cancer respectively, childhood dementia has received little recognition of coordinated action towards solutions.

“Childhood dementia. The fact that these two words go together is appalling. We need to recognise this as a serious and urgent issue and fix it.” CDI Board Director, Sean Murray, has stated.

The report shows that the estimated economic cost of Childhood Dementia is substantial; $40.4 million to the Australian healthcare system, $39.7 million in indirect costs, $233.5 million in costs of life years lost and $75.0 million costs to the National Disability Insurance Scheme (NDIS) in an average year.

With more than 70 disorders causing Childhood Dementia, all posing serious medical challenges and requiring extensive healthcare services, research company THEMA Consulting Pty Ltd have collaborated with CDI to publish key research, in a pro bono partnership.

Media release supplied by Fifty Acres

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

New Initiative Lowering Antipsychotic Medication In Aged Care Facilities

  It is scary enough to cope with the change that dementia and ageing brings without having to journey through the complex side-effects of anti-psychotic medication. From falls, strokes, sleep disturbances and agitation, psychotropic agents have great impacts on all, especially seniors. Pioneered by a team from the Wicking Dementia Research and Education Centre and... Read More

Opioid script changes mean well, but have left some people in chronic pain

Australia’s drug regulator, the Therapeutic Goods Administration (TGA), says opioids should only be used for the short-term management of severe pain (for example, after surgery) and only when other pain medicines are not suitable or effective, for example in cases where patients can’t tolerate non-steroidal anti-inflammatories such as ibuprofen. The new regulations say opioids should no longer be prescribed for chronic non-cancer pain, except in “exceptional circumstances”. Read More

“I am leaving with a heavy heart:” Aged care workers planning to quit the sector over mandatory jabs

“This is going to have a huge impact on residents.” With the deadline looming for aged care staff to have received their first jab by September 17, just how many workers are planning to quit the sector over the issue of mandatory vaccines? HelloCare spoke with aged care workers about the tough decisions they have made. Read More
Advertisement